DIMENSIONAL FUND ADVISORS LP - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 77 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$47,730
-16.3%
40,4490.0%0.00%
Q2 2023$57,033
-6.0%
40,4490.0%0.00%
Q1 2023$60,674
+108246.4%
40,449
-16.5%
0.00%
Q4 2022$56
-99.9%
48,4640.0%0.00%
Q3 2022$55,000
-46.6%
48,464
-25.6%
0.00%
Q2 2022$103,000
-48.0%
65,155
-49.4%
0.00%
Q1 2022$198,000
-37.1%
128,6830.0%0.00%
Q4 2021$315,000
-2.8%
128,6830.0%0.00%
Q3 2021$324,000
-11.7%
128,6830.0%0.00%
Q2 2021$367,000
+21.5%
128,6830.0%0.00%
Q1 2021$302,000
+37.9%
128,683
+3.5%
0.00%
Q4 2020$219,000
+88.8%
124,3600.0%0.00%
Q3 2020$116,000
-8.7%
124,360
-14.9%
0.00%
Q2 2020$127,000
+1.6%
146,088
-3.6%
0.00%
Q1 2020$125,000
-7.4%
151,4870.0%0.00%
Q4 2019$135,000
-11.2%
151,487
-2.2%
0.00%
Q3 2019$152,000154,8500.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,005,379$83,313,0005.12%
Defender Capital, LLC. 4,997,870$12,245,0003.92%
Raffles Associates 543,590$1,332,0001.28%
Prescott General Partners LLC 1,851,851$4,537,0000.16%
DCF Advisers, LLC 85,000$208,0000.08%
Long Focus Capital Management, LLC 215,000$527,0000.07%
Beirne Wealth Consulting Services, LLC 45,000$110,0000.06%
DAFNA Capital Management LLC 80,000$196,0000.05%
Strategic Wealth Investment Group, LLC 65,069$159,0000.04%
Fort Sheridan Advisors LLC 52,931$130,0000.04%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders